QSAM Biosciences Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $125M

QSAM Biosciences General Information

Description

Telix QSAM Inc formerly QSAM Biosciences Inc is a clinical-stage novel radiopharmaceutical company. The company is developing treatments for bone cancer and related diseases.

Contact Information

Website
www.qsambio.com
Formerly Known As
Q2Power Technologies, Q2Earth, Q2power Technologies, Inc.
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 9442 North Capital of Texas Highway, Plaza 1
  • Suite 500
  • Austin, TX 78759
  • United States
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
CleanTech, Life Sciences, Oncology
Corporate Office
  • 9442 North Capital of Texas Highway, Plaza 1
  • Suite 500
  • Austin, TX 78759
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

QSAM Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 03-May-2024 $125M Completed Generating Revenue
9. PIPE 31-Mar-2023 Completed Generating Revenue
8. 2PO 17-May-2022 Cancelled Generating Revenue
7. PIPE 28-Jan-2021 Completed Generating Revenue
6. Merger/Acquisition 01-Nov-2018 Completed Generating Revenue/Not Profitable
5. Reverse Merger 19-Nov-2015 Completed Generating Revenue/Not Profitable
4. Angel (individual) 18-Jun-2015 Completed Startup
3. Angel (individual) 31-Jan-2015 Completed Startup
2. Seed Round 31-Oct-2014 $1.31M $1.66M Completed Startup
1. Seed Round 14-Aug-2014 $350K $350K Completed Startup
To view QSAM Biosciences’s complete valuation and funding history, request access »

QSAM Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Telix QSAM Inc formerly QSAM Biosciences Inc is a clinical-stage novel radiopharmaceutical company. The company is devel
Biotechnology
Austin, TX
5 As of 2022

New York, NY
 

Hamilton, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

QSAM Biosciences Competitors (4)

One of QSAM Biosciences’s 4 competitors is Y-mAbs Therapeutics, a Formerly VC-backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Y-mAbs Therapeutics Formerly VC-backed New York, NY
Fusion Pharmaceuticals Formerly VC-backed Hamilton, Canada
Telix Pharmaceuticals Corporation North Melbourne, Australia
Novartis Corporation Basel, Switzerland
To view QSAM Biosciences’s complete competitors history, request access »

QSAM Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

QSAM Biosciences Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alan Gelband Angel (individual) Minority
Anpath Group Corporation Minority
Bob Clifford Angel (individual) Minority
Brett Conrad Angel (individual) Minority
Checkmate Capital Group Venture Capital Majority
You’re viewing 5 of 15 investors. Get the full list »

QSAM Biosciences Investments & Acquisitions (5)

QSAM Biosciences’s most recent deal was a Corporate Asset Purchase with Agrarian Technologies (license to sell Agrarian's proprietary ABS bio-stimulant). The deal was made on 01-May-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Agrarian Technologies (license to sell Agrarian's proprietary ABS bio-stimulant) 01-May-2019 Corporate Asset Purchase Buildings and Property
Organics By Gosh 23-Jan-2019 Merger/Acquisition Agricultural Chemicals
George B. Wittmer Associates 13-Nov-2018 Merger/Acquisition Environmental Services (B2B)
ERTH Products 30-Sep-2017 Merger/Acquisition Other Agriculture
Anpath Group 19-Nov-2015 Merger/Acquisition Other Healthcare Services
To view QSAM Biosciences’s complete investments and acquisitions history, request access »

Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Organics By Gosh Elgin, TX 1998
ERTH Products Tyrone, GA 1995
George B. Wittmer Associates Green Cove Springs, FL 1994

QSAM Biosciences FAQs

  • When was QSAM Biosciences founded?

    QSAM Biosciences was founded in 2004.

  • Where is QSAM Biosciences headquartered?

    QSAM Biosciences is headquartered in Austin, TX.

  • What is the size of QSAM Biosciences?

    QSAM Biosciences has 5 total employees.

  • What industry is QSAM Biosciences in?

    QSAM Biosciences’s primary industry is Biotechnology.

  • Is QSAM Biosciences a private or public company?

    QSAM Biosciences is a Private company.

  • What is the current valuation of QSAM Biosciences?

    The current valuation of QSAM Biosciences is .

  • What is QSAM Biosciences’s current revenue?

    The current revenue for QSAM Biosciences is .

  • How much funding has QSAM Biosciences raised over time?

    QSAM Biosciences has raised $5.3M.

  • Who are QSAM Biosciences’s investors?

    Alan Gelband, Anpath Group, Bob Clifford, Brett Conrad, and Checkmate Capital Group are 5 of 15 investors who have invested in QSAM Biosciences.

  • Who are QSAM Biosciences’s competitors?

    Y-mAbs Therapeutics, Fusion Pharmaceuticals, Telix Pharmaceuticals, and Novartis are competitors of QSAM Biosciences.

  • When was QSAM Biosciences acquired?

    QSAM Biosciences was acquired on 03-May-2024.

  • Who acquired QSAM Biosciences?

    QSAM Biosciences was acquired by Telix Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »